From mRNA 3′ processing to genome defense: the CPSF complex in transcription-replication conflict and cancer

Jie Li , Xingzhi Xu

Genome Instability & Disease ›› 2026, Vol. 7 ›› Issue (3) : 16

PDF
Genome Instability & Disease ›› 2026, Vol. 7 ›› Issue (3) :16 DOI: 10.1007/s42764-026-00186-y
Review Article
review-article
From mRNA 3′ processing to genome defense: the CPSF complex in transcription-replication conflict and cancer
Author information +
History +
PDF

Abstract

The Cleavage and Polyadenylation Specificity Factor (CPSF) complex, a core regulator of mRNA 3′-end processing, plays an increasingly recognized role in maintaining genomic stability beyond its canonical function in pre-mRNA cleavage and polyadenylation. By facilitating transcription termination, CPSF ensures timely dissociation of RNA Polymerase II (Pol II) from gene termini, thereby preventing transcriptional readthrough, R-loop (three-stranded RNA: DNA hybrids with displaced single-stranded DNA) accumulation, and transcription-replication conflicts (TRCs)—all of which are potent drivers of DNA double-strand breaks and genomic instability. Dysregulation of CPSF subunits (e.g., CPSF3, CPSF4, CPSF6) has been observed in various cancers, including acute myeloid leukemia, glioblastoma, and hepatocellular carcinoma, where aberrant CPSF function disrupts transcriptional fidelity and exacerbates replication stress. Protein interaction analyses further suggest that CPSF associates with DNA replication and repair factors, such as RPA, BARD1, and PARP1, positioning it at the interface of RNA processing and genome maintenance. Given the transcriptional dependency of cancer cells, CPSF—particularly its catalytic subunit CPSF3—has emerged as a promising therapeutic target, with preclinical studies demonstrating that CPSF3 inhibitors can induce transcriptional stress and synthetic lethality. This review comprehensively summarizes the structural and functional roles of the CPSF complex in cancer biology and targeted therapy, and explores its emerging function as a guardian of genomic stability.

Keywords

CPSF complex / Genomic stability / Transcription termination / R-loops / Transcription-replication conflicts (TRCs) / mRNA 3’ end processing

Cite this article

Download citation ▾
Jie Li, Xingzhi Xu. From mRNA 3′ processing to genome defense: the CPSF complex in transcription-replication conflict and cancer. Genome Instability & Disease, 2026, 7 (3) : 16 DOI:10.1007/s42764-026-00186-y

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Alahmari AA, Chaubey AH, Jonnakuti VS, Tisdale AA, Schwarz CD, Cornwell AC, Maraszek KE, Paterson EJ, Kim M, Venkat S, et al. . CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing. RNA, 2024, 30: 281-297

[2]

Aygün I, Miki TS. Nuclear RNA regulation by XRN2 and XTBD family proteins. Cell Structure and Function, 2021, 46: 73-78

[3]

Bayona-Feliu A, Aguilera A. The role of chromatin at transcription-replication conflicts as a genome safeguard. Biochemical Society Transactions, 2021, 49: 2727-2736

[4]

Bejarano DA, Peng K, Laketa V, Börner K, Jost KL, Lucic B, Glass B, Lusic M, Müller B, Kräusslich HG. HIV-1 nuclear import in macrophages is regulated by CPSF6-capsid interactions at the nuclear pore complex. eLife. 2019

[5]

Boreikaite V, Elliott TS, Chin JW, Passmore LA. RBBP6 activates the pre-mRNA 3' end processing machinery in humans. Genes & Development, 2022, 36: 210-224

[6]

Boreikaitė V, Passmore LA. 3'-End processing of eukaryotic mRNA: Machinery, regulation, and impact on gene expression. Annual Review of Biochemistry, 2023, 92: 199-225

[7]

Bratkowski M, Unarta IC, Zhu L, Shubbar M, Huang X, Liu X. Structural dissection of an interaction between transcription initiation and termination factors implicated in promoter-terminator cross-talk. Journal of Biological Chemistry, 2018, 293: 1651-1665

[8]

Buchert M, Papin M, Bonnans C, Darido C, Raye WS, Garambois V, Pélegrin A, Bourgaux JF, Pannequin J, Joubert D, Hollande F. Symplekin promotes tumorigenicity by up-regulating claudin-2 expression. Proceedings of the National Academy of Sciences of the United States of America, 2010, 107: 2628-2633

[9]

Bulli L, Apolonia L, Kutzner J, Pollpeter D, Goujon C, Herold N, Schwarz SM, Giernat Y, Keppler OT, Malim MH, Schaller T. Complex interplay between HIV-1 capsid and MX2-independent alpha interferon-induced antiviral factors. Journal of Virology, 2016, 90: 7469-7480

[10]

Caldecott KW, Ward ME, Nussenzweig A. The threat of programmed DNA damage to neuronal genome integrity and plasticity. Nature Genetics, 2022, 54: 115-120

[11]

Cao Y, Chang H, Li L, Cheng RC, Fan XN. Alteration of adhesion molecule expression and cellular polarity in hepatocellular carcinoma. Histopathology, 2007, 51: 528-538

[12]

Cappell KM, Larson B, Sciaky N, Whitehurst AW. Symplekin specifies mitotic fidelity by supporting microtubule dynamics. Molecular and Cellular Biology, 2010, 30: 5135-5144

[13]

Chan SL, Huppertz I, Yao C, Weng L, Moresco JJ, Yates JR3rd, Ule J, Manley JL, Shi Y. CPSF30 and Wdr33 directly bind to AAUAAA in mammalian mRNA 3' processing. Genes & Development, 2014, 28: 2370-2380

[14]

Chang H, Zhang C, Cao Y. Expression and distribution of symplekin regulates the assembly and function of the epithelial tight junction. Histochemistry and Cell Biology, 2012, 137: 319-327

[15]

Chatterjee N, Walker GC. Mechanisms of DNA damage, repair, and mutagenesis. Environmental and Molecular Mutagenesis, 2017, 58: 235-263

[16]

Chaudhuri E, Jang S, Chakraborty R, Radhakrishnan R, Arnarson B, Prakash P, Cornish D, Rohlfes N, Singh PK, Shi J, et al. . CPSF6 promotes HIV-1 preintegration complex function. Journal of Virology, 2025, 99 e0049025

[17]

Chen W, Guo W, Li M, Shi D, Tian Y, Li Z, Wang J, Fu L, Xiao X, Liu QQ, et al. . Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation. PLoS ONE, 2013, 8 e82728

[18]

Ciccia A, Elledge SJ. The DNA damage response: Making it safe to play with knives. Molecular Cell, 2010, 40: 179-204

[19]

Clerici M, Faini M, Aebersold R, Jinek M. Structural insights into the assembly and polyA signal recognition mechanism of the human CPSF complex. eLife. 2017

[20]

Colgan DF, Manley JL. Mechanism and regulation of mRNA polyadenylation. Genes & Development, 1997, 11: 2755-2766

[21]

Cortazar MA, Erickson B, Fong N, Pradhan SJ, Ntini E, Bentley DL. Xrn2 substrate mapping identifies torpedo loading sites and extensive premature termination of RNA pol II transcription. Genes & Development, 2022, 36: 1062-1078

[22]

Dominski Z. Nucleases of the metallo-beta-lactamase family and their role in DNA and RNA metabolism. Critical Reviews in Biochemistry and Molecular Biology, 2007, 42: 67-93

[23]

Dominski Z. The hunt for the 3' endonuclease. Wiley Interdisciplinary Reviews. RNA, 2010, 1: 325-340

[24]

Dominski Z, Tong L. U7 deciphered: The mechanism that forms the unusual 3' end of metazoan replication-dependent histone mRNAs. Biochemical Society Transactions, 2021, 49: 2229-2240

[25]

Eaton JD, Davidson L, Bauer DLV, Natsume T, Kanemaki MT, West S. Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity. Genes & Development, 2018, 32: 127-139

[26]

Eaton JD, Francis L, Davidson L, West S. A unified allosteric/torpedo mechanism for transcriptional termination on human protein-coding genes. Genes & Development, 2020, 34: 132-145

[27]

Fu Y, Shu ZY, Gu MM. The functional mechanisms and clinical application of read-through drugs. Yi Chuan, 2016, 38: 623-633

[28]

Gaillard H, García-Muse T, Aguilera A. Replication stress and cancer. Nature Reviews Cancer, 2015, 15: 276-289

[29]

Gemayel MC, Bhatwadekar AD, Ciulla T. RNA therapeutics for retinal diseases. Expert Opinion on Biological Therapy, 2021, 21: 603-613

[30]

Giannini M, Porrua O. Senataxin: A key actor in RNA metabolism, genome integrity and neurodegeneration. Biochimie, 2024, 217: 10-19

[31]

Gillis A, Berry S. Global control of RNA polymerase II. Biochimica Et Biophysica Acta Gene Regulatory Mechanisms, 2024, 1867 195024

[32]

Girbig M, Misiaszek AD, Müller CW. Structural insights into nuclear transcription by eukaryotic DNA-dependent RNA polymerases. Nature Reviews Molecular Cell Biology, 2022, 23: 603-622

[33]

Goehring L, Huang TT, Smith DJ. Transcription-replication conflicts as a source of genome instability. Annual Review of Genetics, 2023, 57: 157-179

[34]

Guha S, Bhaumik SR. Transcription-coupled DNA double-strand break repair. DNA Repair, 2022, 109 103211

[35]

Gutierrez PA, Wei J, Sun Y, Tong L. Molecular basis for the recognition of the AUUAAA polyadenylation signal by mPSF. RNA, 2022, 28: 1534-1541

[36]

Hamilton K, Sun Y, Tong L. Biophysical characterizations of the recognition of the AAUAAA polyadenylation signal. RNA, 2019, 25: 1673-1680

[37]

Han X, Jin C, Zheng G, Li Y, Wang Y, Zhang E, Zhu H, Cai Z. Acute myeloid leukemia with CPSF6-RARG fusion resembling acute promyelocytic leukemia with extramedullary infiltration. Ther Adv Hematol, 2021, 12: 2040620720976984

[38]

Han Z, Moore GA, Mitter R, Lopez Martinez D, Wan L, Dirac Svejstrup AB, Rueda DS, Svejstrup JQ. DNA-directed termination of RNA polymerase II transcription. Molecular Cell, 2023, 833253-3267.e3257

[39]

Han Z, Fu S, Johansen JV, Lopez Martinez D, Lou J, Boissière T, He D, Blears D, Olthof AM, Dirac-Svejstrup AB, Svejstrup JQ. A role for human senataxin in contending with pausing and backtracking during transcript elongation. Molecular Cell, 2025, 85: 4166-4182.e4110

[40]

Hofman CR, Tse V, Hu J, Corey DR. Small molecule inhibition of CPSF3 impacts R-loop distribution and abundance. J bioRxiv. 2025

[41]

Hou Y, Sun J, Wu B, Gao Y, Nie H, Nie Z, Quan S, Wang Y, Cao X, Li S. CPSF30-L-mediated recognition of mRNA m(6)A modification controls alternative polyadenylation of nitrate signaling-related gene transcripts in Arabidopsis. Molecular Plant, 2021, 14: 688-699

[42]

Huang C, Shi J, Guo Y, Huang W, Huang S, Ming S, Wu X, Zhang R, Ding J, Zhao W, et al. . A snoRNA modulates mRNA 3' end processing and regulates the expression of a subset of mRNAs. Nucleic Acids Research, 2017, 45: 8647-8660

[43]

Huang J, Liu X, Sun Y, Li Z, Lin MH, Hamilton K, Mandel CR, Sandmeir F, Conti E, Oyala PH, Tong L. An examination of the metal ion content in the active sites of human endonucleases CPSF73 and INTS11. Journal of Biological Chemistry, 2023, 299 103047

[44]

Huang Y, Ji H, Dong J, Wang X, He Z, Cheng Z, Zhu Q. CPSF3 promotes Pre-mRNA splicing and prevents CircRNA cyclization in hepatocellular carcinoma. Cancers (Basel). 2023

[45]

Hunt AG. CPSF30-L: A direct connection between mRNA polyadenylation and m(6)A RNA modification in plants. Molecular Plant, 2021, 14: 711-713

[46]

Ielasi FS, Ternifi S, Fontaine E, Iuso D, Couté Y, Palencia A. Human histone pre-mRNA assembles histone or canonical mRNA-processing complexes by overlapping 3'-end sequence elements. Nucleic Acids Research, 2022, 50: 12425-12443

[47]

Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature, 2009, 461: 1071-1078

[48]

Janssens J, Blokken J, Lampi Y, De Wit F, Zurnic Bonisch I, Nombela I, Van de Velde P, Van Remoortel B, Gijsbers R, Christ F, Debyser Z. CRISPR/Cas9-induced mutagenesis corroborates the role of transportin-SR2 in HIV-1 nuclear import. Microbiology Spectrum, 2021, 9 e01336-21

[49]

Jin X, Li J, Lu W, Deng X, Wei Y, Shu Y, Liu B, Liu Z, Long Y, Zhu X, et al. . Pre-mRNA processing factors differentially impact coordination between co-transcriptional cleavage and transcription termination. Nature Communications, 2025, 16 7086

[50]

Kadam S, McAlpine GS, Phelan ML, Kingston RE, Jones KA, Emerson BM. Functional selectivity of recombinant mammalian SWI/SNF subunits. Genes & Development, 2000, 14: 2441-2451

[51]

Kakegawa J, Sakane N, Suzuki K, Yoshida T. JTE-607, a multiple cytokine production inhibitor, targets CPSF3 and inhibits pre-mRNA processing. Biochemical and Biophysical Research Communications, 2019, 518: 32-37

[52]

Kaufmann I, Martin G, Friedlein A, Langen H, Keller W. Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly(A) polymerase. The EMBO Journal, 2004, 23: 616-626

[53]

Kennedy SA, Frazier ML, Steiniger M, Mast AM, Marzluff WF, Redinbo MR. Crystal structure of the HEAT domain from the Pre-mRNA processing factor Symplekin. Journal of Molecular Biology, 2009, 392: 115-128

[54]

Keon BH, Schäfer S, Kuhn C, Grund C, Franke WW. Symplekin, a novel type of tight junction plaque protein. Journal of Cell Biology, 1996, 134: 1003-1018

[55]

Khalife M, Jia T, Caron P, Shreim A, Genoux A, Cristini A, Pucciarelli A, Leverve M, Lepeltier N, García-Rodríguez N, et al. . SRSF2 overexpression induces transcription-/replication-dependent DNA double-strand breaks and interferes with DNA repair pathways to promote lung tumor progression. NAR Cancer, 2025, 7 zcaf011

[56]

Kim A, Wang GG. R-loop and its functions at the regulatory interfaces between transcription and (epi)genome. Biochimica Et Biophysica Acta Gene Regulatory Mechanisms, 2021, 1864 194750

[57]

Kloeber JA, Chen B, Sun G, King CS, Wang Z, Wang L, Wu Z, Zhu S, Zhao F, Qin H, et al. . KCTD10 is a sensor for co-directional transcription-replication conflicts. Nature, 2025, 648: 210-219

[58]

Kolev NG, Steitz JA. Symplekin and multiple other polyadenylation factors participate in 3'-end maturation of histone mRNAs. Genes & Development, 2005, 19: 2583-2592

[59]

Kolev NG, Yario TA, Benson E, Steitz JA. Conserved motifs in both CPSF73 and CPSF100 are required to assemble the active endonuclease for histone mRNA 3'-end maturation. EMBO Reports, 2008, 9: 1013-1018

[60]

Kong W, Su Y, Teng L, Zhang K, Zou Y, Wang X, Zhang J. The prognostic value and functional role of CPSF3 in hepatocellular carcinoma. Scientific Reports, 2025, 15 45339

[61]

Kumar A, Yu CWH, Rodríguez-Molina JB, Li XH, Freund SMV, Passmore LA. Dynamics in Fip1 regulate eukaryotic mRNA 3' end processing. Genes & Development, 2021, 35: 1510-1526

[62]

Lalonde M, Trauner M, Werner M, Hamperl S. Consequences and resolution of transcription-replication conflicts. Life (Basel). 2021

[63]

Li S, Dong Z, Yang S, Feng J, Li Q. Chaperoning RPA during DNA metabolism. Current Genetics, 2019, 65: 857-864

[64]

Li W, Singh PK, Sowd GA, Bedwell GJ, Jang S, Achuthan V, Oleru AV, Wong D, Fadel HJ, Lee K, et al. . CPSF6-dependent targeting of speckle-associated domains distinguishes primate from nonprimate lentiviral integration. Mbio. 2020

[65]

Li N, Jiang S, Fu R, Lv J, Yao J, Mai J, Hua X, Chen H, Liu J, Lu M. Cleavage and polyadenylation-specific factor 3 induces cell cycle arrest via PI3K/Akt/GSK-3β signaling pathways and predicts a negative prognosis in hepatocellular carcinoma. Biomarkers in Medicine, 2021, 15: 347-358

[66]

Li Z, Liu Y, Liu Y, Zhang Y, Huen MSY, Lu H, Zhang Z, Zhou J, Fang D, Liu T, Huang J. The PARP1-EXD2 axis orchestrates R-loop resolution to safeguard genome stability. Nature Chemical Biology, 2026, 22: 205-216

[67]

Lin P, Chen W, Long Z, Yu J, Yang J, Xia Z, Wu Q, Min X, Tang J, Cui Y, et al. . RBBP6 maintains glioblastoma stem cells through CPSF3-dependent alternative polyadenylation. Cell Discovery, 2024, 10: 32

[68]

Liu L, Manley JL. Modulation of diverse biological processes by CPSF, the master regulator of mRNA 3' ends. RNA, 2024, 301122-1140

[69]

Liu M, Xu R, Merrill C, Hong L, Von Lanken C, Hunt AG, Li QQ. Integration of developmental and environmental signals via a polyadenylation factor in Arabidopsis. PLoS ONE, 2014, 9 e115779

[70]

Liu L, Yu AM, Wang X, Soles LV, Teng X, Chen Y, Yoon Y, Sarkan KSK, Valdez MC, Linder J, et al. . The anticancer compound JTE-607 reveals hidden sequence specificity of the mRNA 3' processing machinery. Nature Structural & Molecular Biology, 2023, 30: 1947-1957

[71]

Liu T, Wang T, Qi L, Liu Y, Shan M, Wang F, Fang Y, Liu S, Wen L, Chen S, et al. . CPSF6-RARγ interacts with histone deacetylase 3 to promote myeloid transformation in RARG-fusion acute myeloid leukemia. Nature Communications, 2025, 16 616

[72]

Liu J, Perren JO, Rogers CM, Nimer S, Wen AX, Halliday JA, Fitzgerald DM, Mei Q, Nehring RB, Crum M, et al. . Endogenous DNA damage at sites of terminated transcripts. Nature, 2025, 640: 240-248

[73]

Lu Y, Wang T, Yan X, Zhang H. Comprehensive assessment of cleavage and polyadenylation specificity factors in hepatocellular carcinoma: Expression, prognostic significance and immune infiltration analysis. Molecular and Clinical Oncology. 2025

[74]

Lu C, Bai X, Zhang H, Zhang Y, Yang M, Zheng Y, Jin Z, Yang W, Guo G, Huang Q, et al. . Mediator regulates transcriptional termination through crosstalk with pre-mRNA 3' end processing factors. Molecular Cell, 2025, 85: 2147-2164.e2110

[75]

Luo Y, Yogesha SD, Cannon JR, Yan W, Ellington AD, Brodbelt JS, Zhang Y. Novel modifications on C-terminal domain of RNA polymerase II can fine-tune the phosphatase activity of Ssu72. ACS Chemical Biology, 2013, 8: 2042-2052

[76]

Ma W, Cui S, Lu Z, Yan X, Cai L, Lu Y, Cai K, Zhou H, Ma R, Zhou S, Wang X. YTH domain proteins play an essential role in rice growth and stress response. Plants (Basel). 2022

[77]

Mandel CR, Kaneko S, Zhang H, Gebauer D, Vethantham V, Manley JL, Tong L. Polyadenylation factor CPSF-73 is the pre-mRNA 3'-end-processing endonuclease. Nature, 2006, 444: 953-956

[78]

Milano L, Gautam A, Caldecott KW. DNA damage and transcription stress. Molecular Cell, 2024, 84: 70-79

[79]

Miller CA, Tricarico C, Skidmore ZL, Uy GL, Lee YS, Hassan A, O'Laughlin MD, Schmidt H, Tian L, Duncavage EJ, et al. . A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG-CPSF6 fusion. Blood Advances, 2018, 2: 1295-1299

[80]

Misra A, Ou J, Zhu LJ, Green MR. Global analysis of CPSF2-mediated alternative splicing: Integration of global iCLIP and transcriptome profiling data. Genomics Data, 2015, 6: 217-221

[81]

Muckenfuss LM, Migenda Herranz AC, Boneberg FM, Clerici M, Jinek M. Fip1 is a multivalent interaction scaffold for processing factors in human mRNA 3' end biogenesis. eLife. 2022

[82]

Passmore LA, Coller J. Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression. Nature Reviews Molecular Cell Biology, 2022, 23: 93-106

[83]

Petropoulos M, Karamichali A, Rossetti GG, Freudenmann A, Iacovino LG, Dionellis VS, Sotiriou SK, Halazonetis TD. Transcription-replication conflicts underlie sensitivity to PARP inhibitors. Nature, 2024, 628: 433-441

[84]

Pommier Y, Sun Y, Huang SN, Nitiss JL. Roles of eukaryotic topoisomerases in transcription, replication and genomic stability. Nature Reviews Molecular Cell Biology, 2016, 17: 703-721

[85]

Ren F, Zhang N, Zhang L, Miller E, Pu JJ. Alternative polyadenylation: A new frontier in post transcriptional regulation. Biomarker Research, 2020, 8: 67

[86]

Romeo V, Griesbach E, Schümperli D. CstF64: Cell cycle regulation and functional role in 3' end processing of replication-dependent histone mRNAs. Molecular and Cellular Biology, 2014, 344272-4284

[87]

Ross NT, Lohmann F, Carbonneau S, Fazal A, Weihofen WA, Gleim S, Salcius M, Sigoillot F, Henault M, Carl SH, et al. . CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcoma. Nature Chemical Biology, 2020, 16: 50-59

[88]

Russo M, Piccolo V, Polizzese D, Prosperini E, Borriero C, Polletti S, Bedin F, Marenda M, Michieletto D, Mandana GM, et al. . Restrictor synergizes with Symplekin and PNUTS to terminate extragenic transcription. Genes & Development, 2023, 37: 1017-1040

[89]

Ryan K, Bauer DL. Finishing touches: Post-translational modification of protein factors involved in mammalian pre-mRNA 3' end formation. International Journal of Biochemistry & Cell Biology, 2008, 40: 2384-2396

[90]

Ryan K, Calvo O, Manley JL. Evidence that polyadenylation factor CPSF-73 is the mRNA 3' processing endonuclease. RNA, 2004, 10: 565-573

[91]

Santivasi WL, Xia F. Ionizing radiation-induced DNA damage, response, and repair. Antioxidants & Redox Signaling, 2014, 21: 251-259

[92]

Saur F, Lesage E, Pradel L, Collins S, Finoux AL, Alghoul E, Le Bozec B, Rocher V, Carette R, Puget N, et al. . Transcriptional repression facilitates RNA:DNA hybrid accumulation at DNA double-strand breaks. Nature Cell Biology, 2025, 27: 992-1005

[93]

Sberna S, Filipuzzi M, Bianchi N, Croci O, Fardella F, Soriani C, Rohban S, Carnevali S, Albertini AA, Crosetto N, et al. . Senataxin prevents replicative stress induced by the Myc oncogene. Cell Death & Disease, 2025, 16: 187

[94]

Schier AC, Taatjes DJ. Structure and mechanism of the RNA polymerase II transcription machinery. Genes & Development, 2020, 34465-488

[95]

Schmidt M, Kluge F, Sandmeir F, Kühn U, Schäfer P, Tüting C, Ihling C, Conti E, Wahle E. Reconstitution of 3' end processing of mammalian pre-mRNA reveals a central role of RBBP6. Genes & Development, 2022, 36: 195-209

[96]

Schönemann L, Kühn U, Martin G, Schäfer P, Gruber AR, Keller W, Zavolan M, Wahle E. Reconstitution of CPSF active in polyadenylation: Recognition of the polyadenylation signal by WDR33. Genes & Development, 2014, 28: 2381-2393

[97]

Scully R, Panday A, Elango R, Willis NA. DNA double-strand break repair-pathway choice in somatic mammalian cells. Nature Reviews Molecular Cell Biology, 2019, 20: 698-714

[98]

Shen P, Ye K, Xiang H, Zhang Z, He Q, Zhang X, Cai MC, Chen J, Sun Y, Lin L, et al. . Therapeutic targeting of CPSF3-dependent transcriptional termination in ovarian cancer. Science Advances, 2023, 9 eadj0123

[99]

Shi X, Qin F, Li H. Confirmation of transcriptional read-through events by RT-PCR. Methods in Molecular Biology, 2020, 2079: 177-186

[100]

Shu Y, Dong Y, Li B, Wang Y, Liao Q, Su Z, Wang J, Zuo P, Yuan H, Wang C, et al. . Knockdown of STK39 inhibits lung cancer brain metastasis by suppressing the CPSF4/NFκB/COX2 pathway. Journal of Neuro-Oncology, 2025, 174: 411-430

[101]

Smith RW, Gray NK. Poly(A)-binding protein (PABP): A common viral target. Biochemical Journal, 2010, 426: 1-12

[102]

Song Y, Sun K, Gong L, Shi L, Qin T, Wang S, Deng W, Chen W, Zheng F, Li G. CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer. Medical Oncology, 2022, 40: 62

[103]

Song Y, Hou J, Wan L, Liu K, Zhou C, Wei S, Zhang G, Lin D, Li Y, Fang Q, et al. . A short report of novel RARG-HNRNPM fusion gene in resembling acute promyelocytic leukemia. Hematology, 2022, 27518-522

[104]

Song P, Cai Z, Tayier S, Tian E, Chen Z, Yu K, Liu L, Jia G. RNA m(6)A regulates the transcription and heterochromatin state of retrotransposons in Arabidopsis. Nature Plants, 2025, 11: 2300-2318

[105]

Stewart M. Polyadenylation and nuclear export of mRNAs. Journal of Biological Chemistry, 2019, 294: 2977-2987

[106]

Sullivan KD, Steiniger M, Marzluff WF. A core complex of CPSF73, CPSF100, and Symplekin may form two different cleavage factors for processing of poly(A) and histone mRNAs. Molecular Cell, 2009, 34: 322-332

[107]

Sun Y, Zhang Y, Hamilton K, Manley JL, Shi Y, Walz T, Tong L. Molecular basis for the recognition of the human AAUAAA polyadenylation signal. Proceedings of the National Academy of Sciences of the United States of America, 2018, 115: E1419-e1428

[108]

Sun Y, Hamilton K, Tong L. Recent molecular insights into canonical pre-mRNA 3'-end processing. Transcription, 2020, 11: 83-96

[109]

Takagaki Y, Manley JL. Complex protein interactions within the human polyadenylation machinery identify a novel component. Molecular and Cellular Biology, 2000, 20: 1515-1525

[110]

Tao Y, Budhipramono A, Huang J, Fang M, Xie S, Kim J, Khivansara V, Dominski Z, Tong L, De Brabander JK, Nijhawan D. Anticancer benzoxaboroles block pre-mRNA processing by directly inhibiting CPSF3. Cell Chemical Biology, 2024, 31: 139-149.e114

[111]

Tarsounas M, Sung P. The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication. Nature Reviews. Molecular Cell Biology, 2020, 21: 284-299

[112]

Teloni F, Michelena J, Lezaja A, Kilic S, Ambrosi C, Menon S, Dobrovolna J, Imhof R, Janscak P, Baubec T, Altmeyer M. Efficient pre-mRNA cleavage prevents replication-stress-associated genome instability. Molecular Cell, 2019, 73: 670-683.e612

[113]

Thomas PE, Wu X, Liu M, Gaffney B, Ji G, Li QQ, Hunt AG. Genome-wide control of polyadenylation site choice by CPSF30 in Arabidopsis. The Plant Cell, 2012, 24: 4376-4388

[114]

Thore S, Raoelijaona F, Talenton V, Fribourg S, Mackereth CD. Molecular details of the CPSF73-CPSF100 C-terminal heterodimer and interaction with Symplekin. Open Biology, 2023, 13 230221

[115]

Tian B, Manley JL. Alternative polyadenylation of mRNA precursors. Nature Reviews Molecular Cell Biology, 2017, 18: 18-30

[116]

Tsutakawa SE, Bacolla A, Katsonis P, Bralić A, Hamdan SM, Lichtarge O, Tainer JA, Tsai CL. Decoding cancer variants of unknown significance for helicase-nuclease-RPA complexes orchestrating DNA repair during transcription and replication. Frontiers in Molecular Biosciences, 2021, 8 791792

[117]

Tu Z, Zheng Y. Role of ATP-dependent chromatin remodelers in hematopoietic stem and progenitor cell maintenance. Current Opinion in Hematology, 2022, 29: 174-180

[118]

Ui A, Chiba N, Yasui A. Relationship among DNA double-strand break (DSB), DSB repair, and transcription prevents genome instability and cancer. Cancer Science, 2020, 111: 1443-1451

[119]

Wang J, Xu C, Zhang Z, Chen FX. Mechanisms of SOSS-Integrator-PP2A complex in attenuating R-loops and promoting genome stability. Clinical and Translational Medicine, 2024, 14 e1519

[120]

Wang Z, Zhang Y, Guo T, He M, Xu Y, Bhattacharjee S, Martienssen RA, Ren J. Dcr1 senses R-loops for RNAPII termination at sites of replication stress and repair pathway choice. Molecular Cell, 2025, 85: 3947-3964.e3910

[121]

West S, Gromak N, Proudfoot NJ. Human 5' –> 3' exonuclease Xrn2 promotes transcription termination at co-transcriptional cleavage sites. Nature, 2004, 432: 522-525

[122]

Xiang K, Nagaike T, Xiang S, Kilic T, Beh MM, Manley JL, Tong L. Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex. Nature, 2010, 467: 729-733

[123]

Xiang K, Manley JL, Tong L. An unexpected binding mode for a Pol II CTD peptide phosphorylated at Ser7 in the active site of the CTD phosphatase Ssu72. Genes & Development, 2012, 26: 2265-2270

[124]

Xie L, Chen L, Zhong C, Yu T, Ju Z, Wang M, Xiong H, Zeng Y, Wang J, Hu H, et al. . MxB impedes the NUP358-mediated HIV-1 pre-integration complex nuclear import and viral replication cooperatively with CPSF6. Retrovirology, 2020, 17: 16

[125]

Xu Z, Pone EJ, Al-Qahtani A, Park SR, Zan H, Casali P. Regulation of aicda expression and AID activity: Relevance to somatic hypermutation and class switch DNA recombination. Critical Reviews in Immunology, 2007, 27367-397

[126]

Xu C, Li C, Chen J, Xiong Y, Qiao Z, Fan P, Li C, Ma S, Liu J, Song A, et al. . R-loop-dependent promoter-proximal termination ensures genome stability. Nature, 2023, 621: 610-619

[127]

Xu Y, Jiao Y, Liu C, Miao R, Liu C, Wang Y, Ma C, Liu J. R-loop and diseases: the cell cycle matters. Molecular Cancer, 2024, 23: 84

[128]

Yang XC, Sullivan KD, Marzluff WF, Dominski Z. Studies of the 5' exonuclease and endonuclease activities of CPSF-73 in histone pre-mRNA processing. Molecular and Cellular Biology, 2009, 2931-42

[129]

Yang XC, Sun Y, Aik WS, Marzluff WF, Tong L, Dominski Z. Studies with recombinant U7 snRNP demonstrate that CPSF73 is both an endonuclease and a 5'-3' exonuclease. RNA, 2020, 26: 1345-1359

[130]

Yang S, Winstone L, Mondal S, Wu Y. Helicases in R-loop formation and resolution. Journal of Biological Chemistry, 2023, 299 105307

[131]

Yates LA, Zhang X, Burgers PM. DNA damage and replication stress checkpoints. Annual Review of Biochemistry, 2025, 94: 195-221

[132]

Yu Z, Lin J, Li QQ. Transcriptome analyses of FY mutants reveal its role in mRNA alternative polyadenylation. The Plant Cell, 2019, 31: 2332-2352

[133]

Zeng Y, Zhang HW, Wu XX, Zhang Y. Structural basis of exoribonuclease-mediated mRNA transcription termination. Nature, 2024, 628: 887-893

[134]

Zhang J, Addepalli B, Yun KY, Hunt AG, Xu R, Rao S, Li QQ, Falcone DL. A polyadenylation factor subunit implicated in regulating oxidative signaling in Arabidopsis thaliana. PLoS ONE, 2008, 3 e2410

[135]

Zhang C, Mao HL, Cao Y. Nuclear accumulation of symplekin promotes cellular proliferation and dedifferentiation in an ERK1/2-dependent manner. Scientific Reports, 2017, 7 3769

[136]

Zhang Y, Sun Y, Shi Y, Walz T, Tong L. Structural insights into the human pre-mRNA 3'-end processing machinery. Molecular Cell, 2020, 77: 800-809.e806

[137]

Zhang W, Yang Z, Wang W, Sun Q. Primase promotes the competition between transcription and replication on the same template strand resulting in DNA damage. Nature Communications, 2024, 15: 73

[138]

Zhang J, Chen F, Tang M, Xu W, Tian Y, Liu Z, Shu Y, Yang H, Zhu Q, Lu X, et al. . The ARID1A-METTL3-m6A axis ensures effective RNase H1-mediated resolution of R-loops and genome stability. Cell Reports, 2024, 43 113779

[139]

Zhao J, Liang JW, Xue HL, Shen SH, Chen J, Tang YJ, Yu LS, Liang HH, Gu LJ, Tang JY, Li BS. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia. Leukemia, 2019, 331387-1399

[140]

Zhao F, Kim W, Kloeber JA, Lou Z. DNA end resection and its role in DNA replication and DSB repair choice in mammalian cells. Experimental and Molecular Medicine, 2020, 52: 1705-1714

[141]

Zhao J, Wang W, Yan L, Chen X, Li W, Li W, Chen T, Chen L. Case report: A rare case of acute myeloid leukemia with CPSF6-RARG fusion resembling acute promyelocytic leukemia. Frontiers in Oncology, 2022, 12 1011023

[142]

Zheng HC, Xue H, Zhang CY. The roles of the tumor suppressor parafibromin in cancer. Frontiers in Cell and Developmental Biology, 2022, 10 1006400

[143]

Zhu HH, Qin YZ, Zhang ZL, Liu YJ, Wen LJ, You MJ, Zhang C, Such E, Luo H, Yuan HJ, et al. . A global study for acute myeloid leukemia with RARG rearrangement. Blood Advances, 2023, 7: 2972-2982

Funding

National Natural Science Foundation of China(U24A20740)

Shenzhen Medical Research Fund (D2403014)

RIGHTS & PERMISSIONS

Shenzhen University School of Medicine; Fondazione Istituto FIRC di Oncologia Molecolare

PDF

6

Accesses

0

Citation

Detail

Sections
Recommended

/